Literature DB >> 12842531

Interim mortality in infants with systemic-to-pulmonary artery shunts.

Kathleen N Fenton1, Ralph D Siewers, Beverley Rebovich, Frank A Pigula.   

Abstract

BACKGROUND: This retrospective review examines the risks and causes of death in infants with aortopulmonary shunts between the time of hospital discharge and planned reintervention.
METHODS: From January 1991 through December 2000, a total of 146 infants aged 60 days or less underwent placement of systemic-to-pulmonary artery shunts and were discharged from the hospital alive. Inpatient, outpatient, and autopsy records were reviewed.
RESULTS: Indications for surgery were single-ventricle anatomy in 90 cases and complex double-ventricle anatomy in 56. Of the patients, 21 (14%) died after discharge and before further planned surgery. Of these 21 infants, 17 (81%) were clinically doing well before sudden death. Autopsies were obtained in 15 cases and attributed the cause of death to shunt thrombosis in 5 infants (33%), myocardial infarction in 2 (13%), and pneumonia or lung disease in 3. Five autopsies were nondiagnostic. The mortality of patients discharged on aspirin (11.1%) was almost identical to that of patients discharged on no anticoagulation (12.3%). Four infants with sudden death had been notably irritable for 24 to 48 hours before death.
CONCLUSIONS: There is a significant incidence of sudden death among infants who have undergone shunting. Death may be preceded by unexplained irritability, and such symptoms should therefore be carefully evaluated. Autopsy-proven shunt thrombosis is one of the leading causes of interim sudden death, and aspirin therapy may not be helpful. Options to reduce interim mortality include alternative regimens of anticoagulation (such as low-molecular weight heparin), alternative conduit material, and earlier reoperation.

Entities:  

Mesh:

Year:  2003        PMID: 12842531     DOI: 10.1016/s0003-4975(03)00168-1

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  18 in total

1.  Antithrombotic therapy in neonates and children: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Paul Monagle; Anthony K C Chan; Neil A Goldenberg; Rebecca N Ichord; Janna M Journeycake; Ulrike Nowak-Göttl; Sara K Vesely
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

2.  Assessment of modified Blalock-Taussig shunt in children with congenital heart disease using multidetector-row computed tomography.

Authors:  Manal Mohamed Helmy Nabo; Yasunobu Hayabuchi; Miki Inoue; Noriko Watanabe; Miho Sakata; Shoji Kagami
Journal:  Heart Vessels       Date:  2010-09-28       Impact factor: 2.037

3.  Right Ventricle-to-Pulmonary Artery Shunt in Pulmonary Atresia with a Ventricular Septal Defect: A Word of Caution.

Authors:  Kwang Ho Choi; Si Chan Sung; Hyungtae Kim; Hyoung Doo Lee; Gil Ho Ban; Geena Kim; Hoon Ko
Journal:  Pediatr Cardiol       Date:  2017-02-03       Impact factor: 1.655

Review 4.  Antiplatelet therapy in pediatric cardiovascular patients.

Authors:  Jennifer S Li; Jane W Newburger
Journal:  Pediatr Cardiol       Date:  2010-03-06       Impact factor: 1.655

5.  Two Cases of Transcatheter Closure of Central Aortopulmonary Shunts: One with an Amplatzer Duct Occluder II and One with an Amplatzer Vascular Plug I.

Authors:  Ahmet Celebi; Ilker Kemal Yucel; Sevket Balli; Mehmet Kucuk
Journal:  Tex Heart Inst J       Date:  2016-06-01

6.  Platelet Inhibition in Shunted Infants on Aspirin at Short and Midterm Follow-Up.

Authors:  Dongngan T Truong; Joyce T Johnson; David K Bailly; Jason R Clawson; Xiaoming Sheng; Phillip T Burch; Madolin K Witte; L LuAnn Minich
Journal:  Pediatr Cardiol       Date:  2016-12-30       Impact factor: 1.655

7.  Prospective study of the incidence and predictors of thrombus in children undergoing palliative surgery for single ventricle physiology.

Authors:  Deanna R Todd Tzanetos; Chang Yu; Marta Hernanz-Schulman; Frederick E Barr; Nancy J Brown
Journal:  Intensive Care Med       Date:  2011-10-07       Impact factor: 17.440

8.  Normal interstage growth after the norwood operation associated with interstage home monitoring.

Authors:  David A Hehir; Nancy Rudd; Julie Slicker; Kathleen A Mussatto; Pippa Simpson; Shun-Hwa Li; Michele A Frommelt; James S Tweddell; Nancy S Ghanayem
Journal:  Pediatr Cardiol       Date:  2012-04-20       Impact factor: 1.655

9.  Balloon dilation of the pulmonary valve in premature infants with tetralogy of Fallot.

Authors:  Vikas Kohli; Sushil Azad; Manvinder Singh Sachdev; Reena Joshi; Raja Joshi; Makram R Ebeid; Ebeid R Makram
Journal:  Pediatr Cardiol       Date:  2008-07-29       Impact factor: 1.655

Review 10.  Primary repair of symptomatic neonates with tetralogy of Fallot with or without pulmonary atresia.

Authors:  Chang-Ha Lee; Jae Gun Kwak; Cheul Lee
Journal:  Korean J Pediatr       Date:  2014-01-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.